| 标题 |
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Erica L. Mayer; F.-C. Bidard; Y.H. Park; W Janni; X. Cynthia; et al 出版日期:2025-10-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)